Jul 23, 2021
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.00 to $0.00.
The split itself did not change the total investment value.
Claritas Pharmaceuticals, Inc. (CLAZF) trades on the Other OTC in the Biotechnology industry.
Claritas Pharmaceuticals, Inc. company overviewThe latest split shown was on July 23, 2021. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 4 reverse splits between June 13, 2012 and July 23, 2021.